Intuitive Surgical, Inc. (TSX:ISRG)
Canada · Delayed Price · Currency is CAD | Market Cap | 171.39B -31.9% |
| Revenue (ttm) | 15.67B +20.7% |
| Net Income | 4.46B +20.4% |
| EPS | 12.38 +21.6% |
| Shares Out | n/a |
| PE Ratio | 38.45 |
| Forward PE | 30.75 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 126,066 |
| Open | 19.04 |
| Previous Close | 20.97 |
| Day's Range | 17.95 - 19.09 |
| 52-Week Range | 17.95 - 31.59 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 16, 2026 |
About Intuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,... [Read more]
Financial Performance
In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.
Financial numbers in USD Financial StatementsNews
Why Intuitive Surgical Stock Plunged Today
Intuitive Surgical (ISRG) shares plummeted Friday after the maker of robotic surgical tools failed to raise the outlook for its flagship product despite better-than-expected second-quarter results.
Intuitive Surgical falls -12.5%
Intuitive Surgical (ISRG) is down -12.5%, or -$50.34 to $352.00.
Intuitive Surgical price target lowered to $470 from $515 at BofA
BofA lowered the firm’s price target on Intuitive Surgical (ISRG) to $470 from $515 and keeps a Buy rating on the shares. Intuitive now expects FY26 worldwide procedure growth to…
Friday's Morning Movers: SPCX Scrubs Test Flights, AAPL Upgrade, ISRG Earnings
Diane King Hall discusses Intuitive Surgical (ISRG) earnings, explaining how GLP-1 trends have hit the company. She also talks about SpaceX (SPCX) shares coming back to Earth after scrubbing Starship'...
Intuitive Surgical falls -10.7%
Intuitive Surgical (ISRG) is down -10.7%, or -$42.92 to $359.41.
Morning Movers: Netflix and Intuitive Surgical sink following quarterly results
Stock futures are lower, extending a selloff in technology shares that has weighed on the broader market despite generally solid corporate earnings and encouraging inflation data earlier in the week.
Intuitive Surgical price target lowered to $454 from $573 at Leerink
Leerink lowered the firm’s price target on Intuitive Surgical (ISRG) to $454 from $573 and keeps an Outperform rating on the shares following the company’s Q2 earnings. The firm cites…
Intuitive Surgical price target lowered to $483 from $577 at Raymond James
Raymond James analyst Jayson Bedford lowered the firm’s price target on Intuitive Surgical (ISRG) to $483 from $577 and keeps an Outperform rating on the shares. The deceleration in U.S.
Intuitive Surgical price target lowered to $575 from $600 at RBC Capital
RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $575 from $600 and keeps an Outperform rating on the shares. The company delivered Q2 revenue and EPS…
Intuitive Surgical price target lowered to $550 from $670 at Stifel
Stifel analyst Rick Wise lowered the firm’s price target on Intuitive Surgical (ISRG) to $550 from $670 and keeps a Buy rating on the shares. Management’s post-release call commentary suggests…
Intuitive Surgical price target lowered to $485 from $520 at TD Cowen
TD Cowen lowered the firm’s price target on Intuitive Surgical (ISRG) to $485 from $520 and keeps a Buy rating on the shares. The firm said shares will will be…
Intuitive Surgical price target lowered to $450 from $550 at JPMorgan
JPMorgan lowered the firm’s price target on Intuitive Surgical (ISRG) to $450 from $550 and keeps an Overweight rating on the shares post the earnings report. The company’s in-line procedures…
Intuitive Surgical falls as Obamacare concerns rekindle medtech demand debate
Intuitive Surgical shares fell more than 12% before the bell on Friday after it maintained its global growth forecast for procedures performed with its da Vinci surgical robots and warned that change...
Intuitive Surgical price target lowered to $400 from $500 at Mizuho
Mizuho lowered the firm’s price target on Intuitive Surgical (ISRG) to $400 from $500 and keeps a Neutral rating on the shares post the earnings report. The company’s systems strength…
Intuitive Surgical price target lowered to $685 from $750 at Bernstein
Bernstein lowered the firm’s price target on Intuitive Surgical (ISRG) to $685 from $750 and keeps an Outperform rating on the shares. The firm cites another strong quarter financially. Sales…
Intuitive Surgical price target lowered to $469 from $512 at BTIG
BTIG lowered the firm’s price target on Intuitive Surgical (ISRG) to $469 from $512 and keeps a Buy rating on the shares after its Q2 results. The company’s procedure growth…
Intuitive Surgical price target lowered to $470 from $580 at Piper Sandler
Piper Sandler analyst Adam Maeder lowered the firm’s price target on Intuitive Surgical (ISRG) to $470 from $580 and keeps an Overweight rating on the shares. The firm notes the…
Intuitive Surgical stock sinks despite earnings beat on 2026 procedure growth outlook
Shares of Intuitive Surgical tumbled about 12% in premarket trading on Friday after the robotic surgery company issued a full-year procedure growth outlook that fell short of investor expectations, ov...
Intuitive Surgical price target lowered to $500 from $525 at Baird
Baird lowered the firm’s price target on Intuitive Surgical (ISRG) to $500 from $525 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results…
Intuitive Surgical price target lowered to $487 from $654 at Wells Fargo
Wells Fargo analyst Larry Biegelsen lowered the firm’s price target on Intuitive Surgical (ISRG) to $487 from $654 and keeps an Overweight rating on the shares. The firm notes Q2…
Intuitive Surgical price target lowered to $454 from $573 at Leerink
Leerink analyst Mike Kratky lowered the firm’s price target on Intuitive Surgical (ISRG) to $454 from $573 and keeps an Outperform rating on the shares.
Intuitive Surgical price target lowered to $500 from $590 at Citi
Citi lowered the firm’s price target on Intuitive Surgical (ISRG) to $500 from $590 and keeps a Buy rating on the shares post the Q2 report. Citi also removed its…
Intuitive Surgical beats quarterly estimates on strong demand for its robotic systems
Intuitive Surgical on Thursday maintained its 2026 forecast for worldwide growth in procedures assisted by its cutting-edge da Vinci robots, after beating Wall Street estimates for second-quarter pr...
Intuitive Surgical Earnings Call Transcript: Q2 2026
Q2 delivered strong 19% revenue growth and robust global adoption of da Vinci and Ion platforms, with total procedures up 16% year-over-year. Guidance for 2026 procedure growth and margins was maintained or raised, while innovation and capital deployment continued to drive expansion.
Intuitive Surgical Earnings release: Q2 2026
Intuitive Surgical released its Q2 2026 earnings on July 16, 2026, summarizing the period's financial results.